Vincent Ribrag Selected Research

BKM-570

8/2014

Bradykinin antagonists and thiazolidinone derivatives as new potential anti-cancer compounds.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Vincent Ribrag Research Topics

Disease

49	Neoplasms (Cancer) 05/2024 - 07/2004
32	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 04/2024 - 05/2004
31	Lymphoma (Lymphomas) 02/2023 - 02/2005
25	Hodgkin Disease (Hodgkin's Disease) 02/2023 - 06/2007
18	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2023 - 10/2007
16	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 04/2024 - 01/2016
13	B-Cell Lymphoma (Lymphoma, B Cell) 01/2023 - 08/2008
12	Multiple Myeloma 04/2024 - 12/2009
12	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 10/2022 - 03/2013
10	Hematologic Neoplasms (Hematological Malignancy) 05/2024 - 12/2009
8	Infections 12/2023 - 01/2017
8	Fatigue 05/2022 - 02/2013
5	Primary Myelofibrosis (Myelosclerosis) 01/2023 - 02/2015
5	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2023 - 07/2004
5	Disease Progression 01/2020 - 11/2016
5	T-Cell Lymphoma (Lymphoma, T Cell) 01/2017 - 03/2007
4	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 02/2024 - 03/2013
4	Residual Neoplasm 11/2023 - 03/2016
4	Neutropenia 05/2022 - 06/2016
4	Febrile Neutropenia 05/2022 - 08/2016
3	Nausea 01/2023 - 02/2013
3	Anemia 01/2021 - 07/2004
3	Burkitt Lymphoma (Burkitt's Lymphoma) 01/2020 - 09/2009
3	Genetic Translocation (Chromosomal Translocation) 04/2013 - 09/2010
2	Diarrhea 01/2023 - 05/2022
2	Splenomegaly 01/2023 - 10/2021
2	Sepsis (Septicemia) 04/2021 - 09/2019
2	Tumor Lysis Syndrome 01/2020 - 01/2016
2	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 01/2020 - 01/2019
2	Thrombocytopenia (Thrombopenia) 01/2019 - 03/2013
2	Glioblastoma (Glioblastoma Multiforme) 08/2014 - 06/2007
2	Glioma (Gliomas) 08/2014 - 06/2007
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 04/2024
1	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 02/2024

Drug/Important Bio-Agent (IBA)

28	Rituximab (Mabthera)FDA Link 04/2024 - 10/2009
15	pembrolizumabIBA 01/2023 - 11/2016
11	Cytarabine (Cytosar-U)FDA LinkGeneric 04/2024 - 03/2011
8	Dexamethasone (Maxidex)FDA LinkGeneric 04/2024 - 08/2016
7	Bortezomib (Velcade)FDA Link 04/2024 - 10/2009
7	Cyclophosphamide (Cytoxan)FDA LinkGeneric 02/2024 - 10/2009
7	Monoclonal AntibodiesIBA 01/2023 - 02/2007
6	Prednisone (Sone)FDA LinkGeneric 02/2024 - 06/2007
6	Vincristine (Oncovin)FDA LinkGeneric 02/2024 - 06/2007
6	Brentuximab VedotinIBA 02/2024 - 11/2016
6	Etoposide (VP 16)FDA LinkGeneric 12/2022 - 04/2011
6	Histone Deacetylase InhibitorsIBA 01/2019 - 04/2015
6	Cyclin D1IBA 04/2016 - 12/2009
5	Doxorubicin (Adriamycin)FDA LinkGeneric 02/2024 - 10/2009
5	AntibodiesIBA 01/2024 - 10/2007
5	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2013
4	obinutuzumabIBA 01/2024 - 09/2020
4	Cisplatin (Platino)FDA LinkGeneric 01/2023 - 08/2016
4	Lenalidomide (CC 5013)FDA Link 10/2022 - 01/2018
4	3- (5- amino- 2- methyl- 4- oxoquinazolin- 3(4H)- yl)piperidine- 2,6- dioneIBA 05/2022 - 01/2020
4	tazemetostatIBA 01/2022 - 01/2018
4	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 03/2007
4	Immune Checkpoint InhibitorsIBA 01/2019 - 10/2017
3	Immunoconjugates (Immunoconjugate)IBA 04/2024 - 01/2014
3	Carboplatin (JM8)FDA LinkGeneric 12/2022 - 11/2020
3	Proteins (Proteins, Gene)FDA Link 01/2019 - 03/2007
3	Melphalan (Alkeran)FDA LinkGeneric 11/2018 - 04/2011
3	abexinostatIBA 01/2017 - 04/2015
2	romidepsin (FK228)FDA Link 02/2024 - 04/2015
2	cemiplimabIBA 02/2023 - 01/2023
2	isatuximabIBA 02/2023 - 01/2023
2	fedratinibIBA 01/2023 - 10/2021
2	Janus Kinase InhibitorsIBA 01/2023 - 10/2021
2	plitidepsin (aplidine)IBA 01/2023 - 03/2013
2	ruxolitinibIBA 01/2023 - 08/2022
2	atezolizumabIBA 01/2023 - 01/2022
2	AnthracyclinesIBA 06/2022 - 06/2020
2	B7-H1 AntigenIBA 01/2022 - 01/2021
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2021 - 11/2020
2	pomalidomideIBA 01/2021 - 09/2019
2	Protein Isoforms (Isoforms)IBA 01/2021 - 06/2007
2	LigandsIBA 01/2019 - 11/2016
2	Carmustine (FIVB)FDA Link 11/2018 - 11/2015
2	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2018 - 01/2018
2	CreatinineIBA 08/2016 - 06/2016
2	coltuximab ravtansineIBA 01/2016 - 01/2014
2	temsirolimus FDA Link 03/2013 - 12/2009
2	TOR Serine-Threonine KinasesIBA 03/2013 - 12/2009
2	EnzymesIBA 02/2013 - 04/2009
2	Farnesyltranstransferase (Farnesyltransferase)IBA 03/2010 - 04/2008
2	tipifarnib (R115777)IBA 03/2010 - 04/2008
2	Antineoplastic Agents (Antineoplastics)IBA 12/2009 - 04/2009

Therapy/Procedure

39	Therapeutics 04/2024 - 07/2004
26	Drug Therapy (Chemotherapy) 02/2024 - 02/2005
16	Stem Cell Transplantation 12/2023 - 04/2011
11	Immunotherapy 05/2024 - 02/2011
7	Radiotherapy 01/2020 - 08/2008
4	Chemoradiotherapy 01/2023 - 02/2005
3	Immunomodulation 01/2021 - 01/2018
3	Combination Drug Therapy (Combination Chemotherapy) 01/2021 - 03/2007
3	Transplantation 11/2020 - 01/2017
2	Investigational Therapies (Experimental Therapy) 10/2021 - 10/2021
2	Duration of Therapy 01/2018 - 11/2017
2	BEAM regimen 11/2015 - 04/2011
2	Intravenous Infusions 01/2014 - 03/2013
2	Aftercare (After-Treatment) 01/2013 - 02/2005